ALTEOGEN Inc. (KOSDAQ:196170)
South Korea · Delayed Price · Currency is KRW 353,500
-6,500 (-1.81%)
At close: Mar 20, 2026
ALTEOGEN Market Cap
ALTEOGEN has a market cap or net worth of 18.91 trillion as of March 20, 2026. Its market cap has decreased by -9.51% in one year.
Market Cap
18.91T
Enterprise Value
18.66T
Revenue
202.18B
Ranking
n/a
PE Ratio
156.21
Stock Price
353,500.00
Market Cap Chart
Since December 12, 2014, ALTEOGEN's market cap has increased from 119.96B to 18.91T, an increase of 15,660.75%. That is a compound annual growth rate of 56.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 18.91T | -21.36% |
| Dec 30, 2025 | 24.04T | 45.74% |
| Dec 30, 2024 | 16.49T | 221.05% |
| Dec 28, 2023 | 5.14T | 160.78% |
| Dec 29, 2022 | 1.97T | -38.41% |
| Dec 30, 2021 | 3.20T | -36.62% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 74.11T |
| Celltrion | 44.21T |
| Samsung Epis Holdings | 13.74T |
| Peptron | 8.07T |
| LigaChem Biosciences | 7.75T |
| SK Biopharmaceuticals | 7.72T |
| HLB Co., Ltd. | 6.87T |
| Voronoi | 5.84T |